Quantification of hepatic and visceral fat by CT and MR imaging: Relevance to the obesity epidemic, metabolic syndrome and NAFLD

British Journal of Radiology

Volumn 89, Issue 1062, 2016, Pages

  Graffy, Peter M ^a   Pickhardt, Perry J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EPIDEMIC; FATTY LIVER; GASTROINTESTINAL RADIOGRAPHY; HUMAN; INCIDENTAL FINDING; INTERMETHOD COMPARISON; INTRAPERITONEAL FAT; LIVER; LIVER EXAMINATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; RADIOLOGIST; REVIEW; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; INTRAABDOMINAL FAT; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSITY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRA-ABDOMINAL FAT; LIVER; MAGNETIC RESONANCE IMAGING; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84968698883     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20151024     Document Type: Review

References (75)

1. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-209. doi: http://dx.doi.org/10.1016/S0140-6736(05)67483-1
2. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res 2001; 9 (Suppl. 4): 228S-33S. doi: http://dx. doi.org/10.1038/oby.2001.123
3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200. doi: http://dx.doi.org/10.1001/jama.286.10.1195
4. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006; 331: 166-74. doi: http://dx.doi.org/10.1097/00000441-200604000-00002
5. Cha E, Akazawa MK, Kim KH, DawkinsCR, LernerHM, UmpierrezG, et al. Lifestyle habits and obesity progression in overweight and obese American young adults: lessons for promoting cardiometabolic health. Nurs Health Sci 2015; 17: 467-75.
6. Chen HL. The scope and impact of obesity in Vermont-strategies for change. Prev Med 2015; 80: 44-6. doi: http://dx.doi.org/10.1016/j.ypmed.2015.03.016
7. Parikh NI, Pencina MJ, Wang TJ, Lanier KJ, Fox CS, D'Agostino RB, et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 2007; 120: 242-50. doi: http://dx.doi.org/10.1016/j. amjmed.2006.06.004
8. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6-28. doi: http://dx.doi.org/10.1093/epirev/mxm007
9. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008; 16: 2323-30. doi: http://dx.doi. org/10.1038/oby.2008.351
10. Strandheim A, Halland H, Saeed S, Cramariuc D, Hetland T, Lønnebakken MT, et al. Obesity-associated metabolic changes influence resting and peak heart rate in women and men. Scand Cardiovasc J 2015; 49: 337-43. doi: http://dx.doi.org/10.3109/14017431.2015.1081273
11. Chaput JP, Saunders TJ, Tremblay MS, Katzmarzyk PT, Tremblay A, Bouchard C. Workplace standing time and the incidence of obesity and type 2 diabetes: a longitudinal study in adults. BMC Public Health 2015; 15: 111. doi: http://dx.doi.org/10.1186/s12889-015-1353-x
12. French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Public Health 2001; 22: 309-35. doi: http://dx.doi.org/10.1146/annurev.publhealth.22.1.309
13. Lycett D. The Association of religious affiliation and body mass index (BMI): an analysis from the health survey for England. J Relig Health 2015; 54: 2249-67. doi: http://dx.doi.org/10.1007/s10943-014-9975-3
14. Birnbaum BA, Hindman N, Lee J, Babb JS. Multi-detector row CT attenuation measurements: assessment of intra-and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007; 242: 109-19. doi: http://dx.doi.org/10.1148/radiol.2421052066
15. Bydder GM, Chapman RW, Harry D, Bassan L, Sherlock S, Kreel L, et al. Computed tomography attenuation values in fatty liver. J Comput Tomogr 1981; 5: 33-5. doi: http://dx. doi.org/10.1016/0149-936X(81)90054-0
16. Bydder GM, Kreel L, Chapman RW, Harry D, Sherlock S, Bassan L. Accuracy of computed tomography in diagnosis of fatty liver. Br Med J 1980; 281: 1042. doi: http://dx.doi.org/10.1136/bmj.281.6247.1042
17. Duman DG, Celikel C, Tuney D, Imeryuz N, Avsar E, Tozun N. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?. Dig Dis Sci 2006; 51: 346-51. doi: http://dx.doi.org/10.1007/s10620-006-3136-9
18. Boyce CJ, Pickhardt PJ, Kim DH, Taylor AJ, Winter TC, Bruce RJ, et al. Hepatic steatosis (Fatty Liver Disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010; 194: 623-8. doi: http://dx.doi.org/10.2214/AJR.09.2590
19. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-56. doi: http://dx.doi.org/10.1148/radiol.11101942
20. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005; 20: 1825-32. doi: http://dx.doi. org/10.1111/j.1440-1746.2005.04058.x
21. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-7. doi: http://dx.doi.org/10.1001/jama.2012.39
22. HamaguchiM, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8. doi: http://dx.doi. org/10.7326/0003-4819-143-10-200511150-00009
23. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23. doi: http://dx.doi.org/10.1053/jhep.2003.50161
24. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008; 103: 3029-35. doi: http://dx.doi.org/10.1111/j.1572-0241.2008.02188.x
25. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-62. doi: http://dx.doi.org/10.1016/S0140-6736(05)67402-8
26. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Med 2006; 23: 469-80. doi: http://dx.doi.org/10.1111/j.1464-5491.2006.01858.x
27. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28. doi: http://dx.doi.org/10.1016/S0140-6736(05)66378-7
28. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404
29. Stepanova M, Afendy M, Vernon GC, Nader F, Younossi ZM. Components of metabolic syndrome and the rising prevalence of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in the United States. Gastroenterology 2011; 140: S988-S.
30. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up Study. Am J Gastroenterol 2009; 104: 861-7. doi: http://dx.doi.org/10.1038/ajg.2009.67
31. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21. doi: http://dx.doi. org/10.1053/j.gastro.2005.04.014
32. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver Study. Hepatology 2005; 42: 44-52. doi: http://dx.doi.org/10.1002/hep.20734
33. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31. doi: http://dx.doi.org/10.1053/j. gastro.2010.09.038
34. Younossi Z, Stepanova M, Afendy M, FangY, YounossiY, MirH, et al. The changing face of chronic liver disease (cld) in the United States: the rising epidemic of non-alcoholic fatty liver disease (NAFLD). J Hepatol 2011; 54: S8-S.
35. Andrés-Blasco I, Herrero-Cervera A, Vinué A, Martínez-Hervaś S, PiquerasL, SanzMJ, et al. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J Endocrinol 2015; 227: 179-91. doi: http://dx.doi.org/10.1530/JOE-15-0219
36. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-23. doi: http://dx.doi.org/10.1126/science.1204265
37. Cosma A, Cecchet D, Gaiani S, Coracina A, Pellizzari P, Pizzi C, et al. Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. Eur J Gastroenterol Hepatol 2015; 27: 1386-91. doi: http://dx.doi.org/10.1097/MEG.0000000000000462
38. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-7. doi: http://dx.doi. org/10.1172/JCI57132
39. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50. doi: http://dx.doi.org/10.1056/NEJMra0912063
40. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 2012; 22: 1075-82. doi: http://dx.doi. org/10.1007/s00330-011-2349-2
41. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (2 Suppl. 1): S99-S112. doi: http://dx.doi.org/10.1002/hep.20973
42. Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, et al. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?. Clin Imaging 2009; 33: 110-5. doi: http://dx.doi.org/10.1016/j. clinimag.2008.06.036
43. Sande EP, Martinsen AC, Hole EO, Olerud HM. Interphantom and interscanner variations for Hounsfield units-establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 2010; 55: 5123-35. doi: http://dx.doi.org/10.1088/0031-9155/55/17/015
44. Tobari M, Hashimoto E, Yatsuji S, Torii N, Shiratori K. Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 2009; 48: 739-46. doi: http://dx.doi.org/10.2169/internalmedicine.48.1869
45. Tang A, Cloutier G, Szeverenyi NM, Sirlin CB. Ultrasound elastography and MR elastography for assessing liver fibrosis: part 2, diagnostic performance, confounders, and future directions. AJR Am J Roentgenol 2015; 205: 33-40. doi: http://dx.doi.org/10.2214/AJR.15.14553
46. Friedman LS. Controversies in liver biopsy: who, where, when, how, why?. Curr Gastroenterol Rep 2004; 6: 30-6. doi: http://dx.doi. org/10.1007/s11894-004-0023-4
47. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it?. Ann Intern Med 1993; 118: 150-3. doi: http://dx.doi.org/10.7326/0003-4819-118-2-199301150-00013
48. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary?. Eur J Gastroenterol Hepatol 2003; 15: 539-43.
49. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906. doi: http://dx.doi.org/10.1053/j. gastro.2005.03.084
50. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, et al; NASH Clinical Research Network. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010; 52: 913-24. doi: http://dx.doi.org/10.1002/hep.23784
51. Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology 2008; 47: 455-60. doi: http://dx.doi. org/10.1002/hep.21984
52. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-7. doi: http://dx.doi.org/10.1111/j.1572-0241.2007.01520.x
53. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307-12. doi: http://dx.doi.org/10.2214/AJR.06.0992
54. Lee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007; 244: 479-85. doi: http://dx. doi.org/10.1148/radiol.2442061177
55. Kim DY, Park SH, Lee SS, Kim HJ, Kim SY, Kim MY, et al. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol 2010; 20: 359-66. doi: http://dx.doi.org/10.1007/s00330-009-1560-x
56. Artz NS, Hines CD, Brunner ST, Agni RM, Kühn JP, Roldan-Alzate A, et al. Quantification of hepatic steatosis with dual-energy computed tomography comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob Mouse. Invest Radiol 2012; 47: 603-10. doi: http://dx.doi.org/10.1097/RLI.0b013e318261fad0
57. Guiu B, Loffroy R, Cercueil JP, Krause D. Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. Radiology 2008; 249: 1081. doi: http://dx.doi. org/10.1148/radiol.2493081034
58. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281-5. doi: http://dx.doi.org/10.1002/jmri.1880050311
59. Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-75. doi: http://dx.doi.org/10.1148/radiol.10100708
60. Zhong L, Chen JJ, Chen J, Li L, Lin ZQ,Wang WJ, et al. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis 2009; 10: 315-20. doi: http://dx.doi.org/10.1111/j.1751-2980.2009.00402.x
61. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized mr-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012; 36: 1011-4. doi: http://dx.doi.org/10.1002/jmri.23741
62. Bashir MR, Zhong X, Nickel MD, Fananapazir G, Kannengiesser SA, Kiefer B, et al. Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy. AJR Am J Roentgenol 2015; 204: 297-306. doi: http://dx.doi.org/10.2214/AJR.14.12457
63. Reeder SB, McKenzie CA, Pineda AR, Yu H, Shimakawa A, Brau AC, et al. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 2007; 25: 644-52. doi: http://dx.doi.org/10.1002/jmri.20831
64. Kramer HP, Kliewer MA, Pickhardt PJ, Hernando D, Chen GH, Reeder SB. Accuracy of liver fat quantification by CT, MR, and US: a prospective comparison with MR spectroscopy. Presented at the 2014 RSNA Scientific Assembly. Chicago, IL: RSNA.
65. Longo R, Ricci C, Masutti F, Vidimari R, Crocé LS, Bercich L, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28: 297-302. doi: http://dx.doi. org/10.1097/00004424-199304000-00006
66. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-9. doi: http://dx.doi.org/10.1007/BF02208670
67. Pickhardt PJ, Hahn L, del Rio AM, Park SH, Reeder SB, Said A. Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. Am J Roentgenology 2014; 202: 752-8. doi: http://dx.doi.org/10.2214/AJR.13.11367
68. Reeder SB, Ranallo F, Taylor AJ. CT and MRI for determining hepatic fat content. AJR Am J Roentgenol 2008; 190: W167. doi: http://dx. doi.org/10.2214/AJR.07.2942
69. Hunt OF, Lubner MG, del Rio AM, Pickhardt PJ. The liver segmental volume ratio (LSVR) for non-invasive detection of cirrhosis: comparison with splenic volume and established linear measures. J Comput Assist Tomogr; in press.
70. Fan JG, Farrell GC. VAT fat is bad for the liver, SAT fat is not! J Gastroenterol Hepatol 2008; 23: 829-32. doi http://dx.doi.org/10.1111/j.1440-1746.2008.05474.x
71. Park BJ, Kim YJ, Kim DH, Jung YJ, Yoon JH, Kim CY, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008; 23: 900-7. doi: http://dx.doi.org/10.1111/j.1440-1746.2007.05212.x
72. Sobhonslidsuk A, Jongjirasiri S, Thakkinstian A, Wisedopas N, Bunnag P, Puavilai G. Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. World J Gastroenterol 2007; 13: 3614-8. doi: http://dx. doi.org/10.3748/wjg.v13.i26.3614
73. Ryckman EM, Summers RM, Liu J, del Rio AM, Pickhardt PJ. Visceral fat quantification in asymptomatic adults using abdominal CT: is it predictive of future cardiac events? Abdom Imaging 2015; 40: 222-6. doi: http://dx.doi.org/10.1007/s00261-014-0192-z
74. Pickhardt PJ, Jee Y, O'Connor SD, del Rio AM. Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome. AJR Am J Roentgenol 2012; 198: 1100-7. doi: http://dx.doi.org/10.2214/AJR.11.7361
75. Hahn L, Reeder SB, Del Rio AM, Pickhardt PJ. Longitudinal changes in liver fat content in asymptomatic adults: hepatic attenuation on unenhanced CT as an imaging biomarker for steatosis. AJR Am J Roentgenol 2015; 205: 1167-72. doi: http://dx.doi.org/10.2214/AJR.15.14724